Results 221 to 230 of about 2,285,924 (374)

Apoptosis in bone marrow of myelodysplastic syndrome patients [letter; comment] [PDF]

, 1996
Andrija Bogdanović, GM Jankovic, M Čolović, DP Trpinac, VZ Bumbasirevic   +4 more
openalex   +1 more source

Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Blood, 2013
E. Papaemmanuil, M. Gerstung, L. Malcovati, S. Tauro, G. Gundem, P. van Loo, Christopher J. Yoon, Peter Ellis, D. Wedge, A. Pellagatti, A. Shlien, M. Groves, S. Forbes, K. Raine, Jonathon Hinton, L. Mudie, Stuart Mclaren, Claire W. Hardy, Calli Latimer, M. D. Della Porta, S. O’Meara, Ilaria Ambaglio, A. Gallì, A. Butler, G. Walldin, J. Teague, L. Quek, A. Sternberg, C. Gambacorti-Passerini, N. Cross, A. Green, J. Boultwood, P. Vyas, E. Hellstrom-Lindberg, D. Bowen, M. Cazzola, M. Stratton, P. Campbell   +37 more
semanticscholar   +1 more source

The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified‐Release Posaconazole Prophylaxis

Transplant Infectious Disease, EarlyView.
This single‐center retrospective cohort study on 300 allogeneic hematopoietic stem cell transplant recipients from January 2017 to May 2020, in which posaconazole modified release was the most common primary antifungal prophylaxis, demonstrated a breakthrough invasive fungal disease (bIFD) rate of 9%, with associated significant all‐cause mortality at ...
Shio Yen Tio, Chin Fen Neoh, David Ritchie, Lynette Chee, David C. M. Kong, Leon J. Worth, Michelle K. Yong, Monica A. Slavin   +7 more
wiley   +1 more source

Advances and challenges in the treatment of myelodysplastic syndromes. [PDF]

Exp Hematol Oncol
Thalla R, Mack R, Kosti-Schwartz J, Breslin P, Zhang J.   +4 more
europepmc   +1 more source

Apoptosis Resistance of Blood Cells From Patients With Paroxysmal Nocturnal Hemoglobinuria, Aplastic Anemia, and Myelodysplastic Syndrome [PDF]

, 1997
Kentaro Horikawa, Hideki Nakakuma, Tatsuya Kawaguchi, Norihiro Iwamoto, Shoichi Nagakura, Tadashi Kagimoto, Kiyoshi Takatsuki   +6 more
openalex   +1 more source

Respiratory Syncytial Virus Exceeded SARS‐CoV‐2 and Influenza in Lower Respiratory Infection and Mortality Rates Among Patients With Hematologic Malignancies During the 2023–2024 Respiratory Virus Season

Transplant Infectious Disease, EarlyView.
During the 2023‐2024 respiratory viral season, respiratory syncytial virus infection was associated with worse outcomes compared to infections caused by SARS‐CoV‐2 and influenza virus in patients with hematologic malignancies ABSTRACT Background Respiratory viral infections (RVIs) significantly impact patients with hematologic malignancies (HMs ...
Tali Shafat, Amy Spallone, Fareed Khawaja, Ying Jiang, Jennifer Jackson, Lior Nesher, Roy F. Chemaly   +6 more
wiley   +1 more source

Novel agents and evolving strategies for anemia management in lower-risk myelodysplastic syndromes. [PDF]

Blood Res
Hong J.
europepmc   +1 more source

Bloom's Syndrome Complicated by Myelodysplastic Syndrome and Multiple Neoplasia.

, 1993
Yoshihito Iwahara, Kazuyoshi� Ishii, Seiji Watanabe, Hirokuni Taguchi, Hiroshi Hara, Isao Miyoshi   +5 more
openalex   +2 more sources

Improved survival after acute graft-versus-host disease diagnosis in the modern era [PDF]

, 2017
et al.,, Hayashi, Robert J, Vig, Ravi
core   +1 more source

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Journal of Clinical Oncology, 2017
B. Scott, M. Pasquini, B. Logan, Juan Wu, S. Devine, D. Porter, R. Maziarz, E. Warlick, H. Fernandez, E. Alyea, M. Hamadani, A. Bashey, S. Giralt, N. Geller, E. Leifer, J. Le-Rademacher, A. Mendizabal, M. Horowitz, H. Deeg, M. Horwitz   +19 more
semanticscholar   +1 more source